Showing results (21-30 of 61) with videos related to
Sort By:
Pageof 7
Headache|September 24, 2005
Removing barriers to appropriate migraine treatment: formulary limitations and triptan package sizeStephen D Silberstein, David Dodick, Jim KesslickCurrent Pain and Headache Reports|May 17, 2007
Patent foramen ovale and migraineHans-Christoph Diener, Tobias Kurth, David DodickCurrent Pain and Headache Reports|November 17, 2010
Treatment of chronic migraineHans-Christoph Diener, Dagny Holle, David DodickCurrent Opinion in Neurology|May 15, 2007
Patent foramen ovale, stroke, and cardiovascular disease in migraineHans-Christoph Diener, Tobias Kurth, David DodickHeadache|April 19, 2005
Management of chronic daily headache: challenges in clinical practiceJoel R Saper, David Dodick, Jonathan P GladstoneThe Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 24, 2013
Canadian Headache Society Guideline: acute drug therapy for migraine headacheIrene Worthington, Tamara Pringsheim, Marek J Gawel, et al.Headache|November 3, 2006
DHE in the pharmacotherapy of migraine: potential for a larger roleJoel R Saper, Stephen Silberstein, David Dodick, et al.CNS Drugs|February 9, 2005
Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled studyDavid Dodick, Jan Brandes, Arthur Elkind, et al.Cephalalgia : an International Journal of Headache|March 30, 2011
Pathophysiology of medication overuse headache: insights and hypotheses from preclinical studiesIan D Meng, David Dodick, Michael H Ossipov, et al.Headache|May 15, 2002
How does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trialsCarl G H Dahlöf, David Dodick, Andrew J Dowson, et al.Pageof 7